source
- BioNTech appoints Sobi's Guido Oelkers as new CEO, to start by Feb 1 2027BioNTech announced that Guido Oelkers, currently a leader at Swedish biotech company Sobi, will become its next chief executive officer. Oelkers is expected to take over the role no later than Feb…
- FDA releases new guidances on adhesives and skin irritation testing for transdermal drug productsThe U.S. Food and Drug Administration has issued two new guidances that focus on transdermal and topical delivery systems used for generic medicines. One guidance, finalized, provides recommendati…